De novo design of potent and selective mimics of IL-2 and IL-15

Overview of attention for article published in Nature, January 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 14 news outlets
blogs: 3 blogs
twitter: 276 X users
patent: 93 patents
facebook: 5 Facebook pages
wikipedia: 8 Wikipedia pages

googleplus: 3 Google+ users
reddit: 1 Redditor
f1000: 1 research highlight platform
q&a: 1 Q&A thread
video: 1 YouTube creator
podcasts: 1 podcast

Readers on

mendeley: 1043 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 16 news stories from 14 outlets.

Therapeutic Proteins: Types, Design and Production

Technology Networks, 29 Aug 2025

Therapeutic proteins are a major class of modern pharmaceutical used to treat a wide range of diseases, including cancer…

The Valencian who "by chance" ended up doing research with the Nobel Prize in Chemistry tells us the secrets of his work - World Today News

World Today News, 17 Oct 2024

It was in 2016 when Alfredo Quijano (Valencia, 1993) arrived in Seattle to begin his doctorate in Bioengineering at the…

Interleukin-2: Kunstprotein gegen Krebs

Pharmazeutische Zeitung, 13 Jan 2020

Rekombinantes Interleukin-2 (Aldesleukin) war eines der ganz frühen rekombinanten Proteine, die mit viel Hoffnung für die…

De novo design of artificial IL-2 mimic for the treatment of cancer [PreClinical]

2 Minute Medicine , 07 Feb 2019

1. IL-2 is a central cytokine that enhances the immune response, with considerable potential for the treatment of cancer.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 12 additional news stories.